Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. The company is headquartered in New York City, New York and currently employs 25 full-time employees. The company went IPO on 2014-03-26. The firm is advancing its lead product candidate Actimab-A, a CD33 targeting therapeutic, as potential backbone therapy in acute myeloid leukemia (AML) and other myeloid malignancies leveraging the mutation agnostic alpha-emitter radioisotope payload Actinium-225 (Ac-225). The firm is engaged with the National Cancer Institute (NCI) under the Cooperative Research and Development Agreement (CRADA) for development of Actimab-A in AML and other myeloid malignancies. ATNM-400 is the Company's novel non-PSMA targeting Ac-225 radiotherapy for prostate cancer. Iomab-ACT, its conditioning candidate, is being developed to improve patient access and outcomes for potentially curative cell and gene therapies. Its Iomab-B program is an induction and conditioning agent prior to bone marrow transplant in patients with r/r AML, which it is seeking a potential strategic partner for the United States.
ATNM stock price ended at $0 on Çarşamba, after dropping NaN%
On the latest trading day Jun 03, 2026, the stock price of ATNM fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for ATNM decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
ATNMTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 0
Nötr Sinyaller 7
Satış Sinyalleri 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
ATNM, şu anda 0 alım sinyali ve 0 satım sinyali vermektedir. Hisse senedi --'ten beri Aşağı yönlü trend durumundadır ve bu dönemde toplam -- fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Neutral görünüm işaret etmektedir.
ATNM için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek ATNM için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.
Takip Soruları
Teknik analiz göstergeleri ATNM için nasıl uygulanır?
Teknik analize göre, Actinium Pharmaceuticals Inc Neutral toplam sinyaline sahiptir. Actinium Pharmaceuticals Inc 0 adet al sinyali, 7 adet nötr sinyal ve 0 adet sat sinyali vardır.
Actinium Pharmaceuticals Inc için RSI nedir?
Actinium Pharmaceuticals Inc için mevcut RSI 0 'dir, bu da nötr durumunu gösterir
Önümüzdeki 12 ay için Actinium Pharmaceuticals Inc fiyatı nedir?
Actinium Pharmaceuticals Inc ATNM önümüzdeki 12 ay için $0 olarak tahmin edilmektedir.
Actinium Pharmaceuticals Inc ne kadar yükselmesi bekleniyor?
Wall Street analistlerine göre, Actinium Pharmaceuticals Inc $0 yüksek tahminine ulaşması beklenmektedir.